Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Active parent page: Institutes and Divisions
    • News and Events
    • Contact

UK Parkinson's Disease Consortium (UKPDC)

Parkinson’s disease is a progressive condition of brain degeneration resulting in tremors, stiffness and slowness of movement. Currently there are no reliable measures to track Parkinson’s progression in the brain, so clinicians rely on monitoring symptoms. Treatments can alleviate the symptoms, but do not slow the progression of the disease.

Breadcrumb trail

  • Research departments
  • Clinical and Movement Neurosciences
  • Centres and projects

Faculty menu

  • Queen Square Brain Bank
  • Aligning Science Across Parkinson’s (ASAP)
  • PD-Care
  • Unit of Functional Neurosurgery
  • Sara Koe PSP Centre
  • Current page: UK Parkinson's Disease Consortium (UKPDC)

UK Parkinson's Disease Consortium (UKPDC) is a group of world-leading genetic, biochemical, clinical, and other scientific researchers, who possess complementary expertise, technology, and resources to identify and tackle the causes of Parkinson’s disease (PD).

Scientific aims:

We will bring together physical chemistry, computational modelling, genetics and neurobiology in order to understand why some brain cells succumb while others are resistant to the pathological processes of the disease. By mapping the genetic and molecular processes that underlie the disease, we aim to distinguish cause and effect and deliver new targets for therapeutics, diagnostics and biomarkers of disease.

We will explore evidence that the increase in the alpha-synuclein protein that causes Parkinson’s may come from the gut and travel along nerves that go to the brain. We will investigate whether it’s possible to modify the gut microbiomes of people who are at risk of Parkinson’s, in order to prevent the disease before it starts.

We will investigate the genome at the single cell level in brain and gut, to allow full understanding of the role of genes in Parkinson’s disease.

We aim to provide a comprehensive description of the genetic factors and biological processes that cause Parkinson’s, and make, freely available, the first oligomer map of the PD brain and the resulting genes and pathways. This unique resource will enable the community to develop new hypotheses, explore disease mechanisms and identify new therapeutic targets.

We will perform fundamental, state-of-the-art experimentation to better comprehend the biology that is controlled by LRRK2, a major cause of inherited Parkinson's disease. The goal is to gain a much better understanding of LRRK2-driven Parkinson's disease, hopefully providing a foundation for the development of future therapies.

We are funded by Aligning Science Across Parkinson’s (ASAP), whose grant implementation partner is The Michael J. Fox Foundation for Parkinson's research.

Vacancies:

None
 


 

Researchers:

Professor Tony Schapira

Professor Nicholas Wood

Professor John Hardy

Professor Dario Alessi

Professor Miratul Muqit

Dr Christos Proukakis

Professor Mina Ryten

Professor Sonia Gandhi

Dr Jane MacNaughtan

Dr Zane Jaunmuktane

Professor Huw Morris

Professor Tom Warner

Professor Tammaryn Lashley

Professor Helene Plun-Favreau

Professor Paul Whiting

Professor Robin Ketteler

Dr Steven F. Lee

Professor Michele Vendruscolo

Professor Frances Platt

Professor Maria Grazia Spillantini

Professor Patrick Lewis

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in